High-Alcohol Drug Formulations
High-Alcohol Drug Formulations
The Central Government amended the Drugs Rules, 1945, introducing stricter licensing and oversight for high-alcohol drug formulations to curb misuse and protect public health.
Background:
Certain medicines containing ethyl alcohol earlier enjoyed regulatory exemptions, allowing easier retail sale. Rising misuse of these formulations as low-cost alcohol substitutes led to stricter regulations.
Key Amendments:
Removal of Exemption: Licensing exemptions under Schedule K for ethyl alcohol-based formulations have been withdrawn.
New Regulatory Threshold:
- Formulations containing more than 12% v/v ethyl alcohol in quantities above 30 ml are no longer exempt.
- Such products now require manufacturing and retail licenses under the Drugs and Cosmetics Act, 1940.
Oversight Objective: The amendment aims to ensure strict monitoring of the manufacture, distribution, and sale of high-alcohol medicinal products.
The Drugs and Cosmetics Act, 1940 & Drugs Rules, 1945:
The principal legal framework regulating the import, manufacture, distribution, and sale of drugs in India.
Schedule K Explained:
Purpose: Schedule K exempts certain categories of drugs from selected provisions of Chapter IV of the Act and related rules.
Intent: It was designed to simplify compliance and improve access to essential household medicines by reducing licensing requirements.
The Shift: High-alcohol formulations have now been moved from the exempt category to a strictly regulated one.
Gray-Market Monitoring:
Enforcing licensing rules across numerous small and rural pharmacies remains difficult.
Compliance Burden:
Small pharmaceutical manufacturers may face higher costs and procedural challenges in obtaining licenses.
Distinguishing Genuine Use:
Regulators must ensure that legitimate Ayurvedic, homeopathic, and allopathic formulations using alcohol as a solvent or preservative remain readily available.
Allow manufacturers and retailers sufficient time to obtain required licenses without disrupting medicine supplies.
Use existing drug-tracking systems to monitor the supply chain of formulations exceeding the 12% v/v threshold.
Issue uniform guidelines to state drug controllers for distinguishing genuine therapeutic products from those prone to misuse.
The amendment to the Drugs Rules, 1945 strengthens regulation of high-alcohol formulations, reducing their misuse while safeguarding access to genuine medicines. Effective implementation with streamlined licensing and robust monitoring will enhance public health protection.